Health-related quality of life after bladder preservation therapy for muscle invasive bladder cancer

International Journal of Urology

Volumn 15, Issue 5, 2008, Pages 403-406

  Hashine, Katsuyoshi ^a   Miura, Noriyoshi ^a   Numata, Kousaku ^a   Shirato, Akitomi ^a   Sumiyoshi, Yoshiteru ^a   Kataoka, Masaaki ^a  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

Author keywords

Bladder preservation; Muscle invasive bladder cancer; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER METASTASIS; BLADDER PRESERVATION THERAPY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MICTURITION; MULTIVARIATE ANALYSIS; MUSCLE METASTASIS; PAIN ASSESSMENT; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL SIGNIFICANCE; TRANSURETHRAL RESECTION; URINARY DYSFUNCTION;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; QUALITY OF LIFE; URINARY BLADDER NEOPLASMS;

EID: 43049147076     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02032.x     Document Type: Article

References (22)

1. Shariat SF, Karakiewicz PI, Palapattu GS et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J. Urol. 2006 176 : 2414 22.
2. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J. Clin. Oncol. 2001 19 : 666 75.
3. Madersbacher S, Hochreiter W, Burkhand F et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant therapy. J. Clin. Oncol. 2003 21 : 690 6.
4. Takahashi A, Tsukamoto T, Tobisu K et al. Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis. Jpn. J. Clin. Oncol. 2004 34 : 14 19.
5. Shipley WU, Winter KA, Kaufman DS et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J. Clin. Oncol. 1998 16 : 3576 83.
6. Kaufman DS, Winter KA, Shipley WU et al. The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. Oncologist 2000 5 : 471 6.
7. Rodel C, Grabenbauer GG, Kuhn R et al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J. Clin. Oncol. 2002 20 : 3061 71.
8. Tester W, Porter A, Asbell S et al. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int. J. Radiat. Oncol. Biol. Phys 1993 25 : 783 90.
9. Sumiyoshi Y, Hashine K, Karashima T, Kasahara Y, Inoue Y. Preliminary results of bladder preservation by concurrent intraarterial chemotherapy and radiotherapy for muscle-invasive bladder cancer. Int. J. Urol. 1998 5 : 225 9.
10. Zietman AL, Sacco D, Skowronski U et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J. Urol. 2003 170 : 1772 6.
11. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J. Clin. Epidemiol. 1998 51 : 1037 44.
12. Takegami M, Suzukamo Y, Sanda MG et al. The Japanese translation and cultural adaptation of expanded prostate cancer index composite (EPIC). Jpn. J. Urol. 2005 96 : 657 69.
13. Yoneda T, Adachi H, Urakami S et al. Health related quality of life after orthotopic neobladder construction and its comparison with normative values in the Japanese population. J. Urol. 2005 174 : 1944 7.
14. George L, Bladou F, Bardou VJ et al. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. Urology 2004 64 : 488 93.
15. de la Rosa F, Garcia-Carbonero R, Passas J, Rosino A, Lianes P, Paz-Ares L. Primary cisplatin, methotrexate and vinblastine chemotherapy with selective bladder preservation for muscle invasive carcinoma of the bladder: long-term followup of a prospective study. J. Urol. 2002 167 : 2413 8.
16. Miyanaga N, Akaza H, Okumura T et al. A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: a prospective study. Int. J. Urol. 2000 7 : 41 8.
17. Litwin MS, Sadetsky N, Pasta DJ, Lubeck DP. Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE. J. Urol. 2004 172 : 515 19.
18. Namiki S, Tochigi T, Kuwahara M et al. Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer. Int. J. Urol. 2004 11 : 619 27.
19. Hinotsu A, Niimi M, Akaza H et al. Development of Japanese version of QOL questionnaire for bladder and prostate cancer patients using FACT-BL and P: pilot study. Jpn J. Cancer Chemother. 1999 26 : 657 66.
20. Wei JT, Dunn RL, Sandler HM et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J. Clin. Oncol. 2002 20 : 557 66.
21. Miller DC, Sanda MG, Dunn RL et al. Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J. Clin. Oncol. 2005 23 : 2772 80.
22. Allareddy V, Kennedy J, West MM, Konety BR. Quality of life in long-term survivors of bladder cancer. Cancer 2006 106 : 2355 62.